Search Results for "q3-earnings"

Indian pharma likely to report tepid earnings growth for Q3 FY17
Challenges in the US including pricing pressure and increased regulatory scrutiny may impact the earnings of Indian generic drugmakers
...
- Home /
- Search
Latest News
Advertisement
Advertisement
Advertisement